We did not observe a significant trend in later stages of CKD within patients with the CNV compared to those without ( Figure S2 B).
← all excerpts
Deletions in <i>VANGL1</i> are a risk factor for antibody-mediated kidney disease.
1
—
—
We did not observe a significant trend in later stages of CKD within patients with the CNV compared to those without ( Figure S2 B).